Thermo Fisher Scientific Inc. (LON: 0R0H)

Thermo Fisher Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 27, 2024	Dec 30, 2023	Dec 30, 2022	Dec 30, 2021	Dec 30, 2020	Dec 30, 2019
Cash & Equivalents	4,645	8,077	8,524	4,477	10,325	2,399
Short-Term Investments	2,000	-	-	-	-	-
Cash & Short-Term Investments	6,645	8,077	8,524	4,477	10,325	2,399
Cash Growth	8.03%	-5.24%	90.40%	-56.64%	330.39%	14.08%
Accounts Receivable	9,796	9,664	9,427	8,945	6,472	4,952
Receivables	9,796	9,664	9,427	8,945	6,472	4,952
Inventory	5,430	5,088	5,634	5,051	4,029	3,370
Restricted Cash	11	6	12	13	10	21
Other Current Assets	1,901	1,754	1,632	1,627	1,121	1,151
Total Current Assets	23,783	24,589	25,229	20,113	21,957	11,893
Property, Plant & Equipment	9,412	11,004	10,873	9,864	6,687	5,448
Long-Term Investments	91	45	154	63	53	67
Goodwill	46,726	44,020	41,196	41,924	26,041	25,714
Other Intangible Assets	16,262	16,707	17,478	20,146	12,685	14,014
Long-Term Accounts Receivable	8	4	7	9	11	17
Other Long-Term Assets	4,082	2,357	2,217	3,004	1,618	1,228
Total Assets	100,364	98,726	97,154	95,123	69,052	58,381
Accounts Payable	2,606	2,872	3,381	2,867	2,175	1,920
Accrued Expenses	5,161	4,516	5,120	5,093	3,939	2,380
Short-Term Debt	-	-	310	2,522	-	676
Current Portion of Long-Term Debt	4,116	3,604	5,269	-	2,628	-
Current Portion of Leases	-	268	272	281	184	167
Current Unearned Revenue	2,663	2,689	2,601	2,655	1,271	916
Other Current Liabilities	55	63	57	18	107	138
Total Current Liabilities	14,601	14,012	17,010	13,436	10,304	6,197
Long-Term Debt	31,197	31,410	28,784	32,148	19,146	17,089
Long-Term Leases	200	1,429	1,523	1,388	633	571
Long-Term Unearned Revenue	1,428	1,499	1,179	1,238	763	594
Long-Term Deferred Tax Liabilities	1,123	1,922	2,849	3,837	1,794	2,192
Other Long-Term Liabilities	2,716	1,229	1,338	1,595	1,356	1,511
Total Liabilities	51,265	51,884	53,006	54,146	34,535	28,706
Common Stock	444	442	441	439	437	434
Additional Paid-In Capital	17,831	17,286	16,743	16,174	15,579	15,064
Retained Earnings	51,421	47,364	41,910	35,431	28,116	22,092
Treasury Stock	-18,227	-15,133	-12,017	-8,922	-6,818	-5,236
Comprehensive Income & Other	-2,477	-3,224	-3,099	-2,329	-2,807	-2,679
Total Common Equity	48,992	46,735	43,978	40,793	34,507	29,675
Minority Interest	107	107	170	184	10	-
Shareholders' Equity	49,099	46,842	44,148	40,977	34,517	29,675
Total Liabilities & Equity	100,364	98,726	97,154	95,123	69,052	58,381
Total Debt	35,513	36,711	36,158	36,339	22,591	18,503
Net Cash (Debt)	-28,868	-28,634	-27,634	-31,862	-12,266	-16,104
Net Cash Per Share	-75.13	-73.80	-70.14	-80.26	-30.74	-39.96
Filing Date Shares Outstanding	382.5	381.31	385.43	391.19	393.79	398.83
Total Common Shares Outstanding	382.5	386.65	390.51	394.43	396.67	398.74
Working Capital	9,182	10,577	8,219	6,677	11,653	5,696
Book Value Per Share	128.08	120.87	112.62	103.42	86.99	74.42
Tangible Book Value	-13,996	-13,992	-14,696	-21,277	-4,219	-10,053
Tangible Book Value Per Share	-36.59	-36.19	-37.63	-53.94	-10.64	-25.21
Land	-	458	454	431	410	396
Buildings	-	3,593	3,153	2,575	2,192	1,873
Machinery	-	9,235	7,967	7,020	6,975	5,495
Construction In Progress	-	2,238	2,695	2,567	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.